Company Filing History:
Years Active: 2023
Title: Antonio Maria Ruda: Innovator in Bromodomain Inhibitor Synthesis
Introduction
Antonio Maria Ruda is a notable inventor based in South Glamorgan, GB. He has made significant contributions to the field of chemical synthesis, particularly in the development of bromodomain inhibitors. His work is characterized by innovative processes that enhance the purity and scalability of chemical compounds.
Latest Patents
Ruda holds a patent for a "Process for the preparation of bromodomain inhibitor." This invention provides processes for the synthesis and purification of a bromodomain inhibitor, referred to as Compound 1. The patent encompasses various forms of the compound, including crystalline forms, amorphous forms, solvates, and hydrates. The disclosed methods offer scalable synthesis routes that yield a highly pure final product. Additionally, the patent details methods for isolating the most stable polymorph of Compound 1 through crystallization from formic acid and water.
Career Highlights
Antonio Maria Ruda is associated with Celgene Quanticel Research, Inc., where he applies his expertise in chemical synthesis. His innovative approaches have contributed to advancements in the pharmaceutical industry, particularly in the development of therapeutic agents.
Collaborations
Ruda has collaborated with notable colleagues, including John Fitzgerald Traverse and Kelvin Hin-Yeong Yong. These partnerships have fostered a collaborative environment that enhances research and development efforts in their field.
Conclusion
Antonio Maria Ruda's contributions to the synthesis of bromodomain inhibitors exemplify the impact of innovative thinking in the pharmaceutical industry. His work continues to influence the development of effective therapeutic agents.